Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 99,465 | 86,242 | 81,426 | 75,570 | 68,534 |
| Operating Income | -99,465 | -86,242 | -81,426 | -75,570 | -68,534 |
| Other Income | 135 | 120 | 75 | 121 | 137 |
| Pre-tax Income | -99,330 | -86,122 | -81,351 | -75,449 | -68,397 |
| Net Income Continuous | -99,330 | -86,122 | -81,351 | -75,449 | -68,397 |
| Net Income | $-99,330 | $-86,122 | $-81,351 | $-75,449 | $-68,397 |
| EPS Basic Total Ops | -0.64 | -0.55 | -0.53 | -0.51 | -0.46 |
| EPS Basic Continuous Ops | -0.64 | -0.55 | -0.53 | -0.51 | -0.45 |
| EPS Diluted Total Ops | -0.64 | -0.55 | -0.53 | -0.51 | -0.46 |
| EPS Diluted Continuous Ops | -0.64 | -0.55 | -0.53 | -0.51 | -0.45 |
| EBITDA(a) | $-94,165 | $-80,962 | $-74,451 | $-73,132 | $-66,707 |